The material in this article has been gathered from the first stage (T1) of a
longitudinal study that considered the psycho-social issues associated
with the treatment of pediatric ALL and associated hematological disorders
including AML and the lymphomas. The Royal Children’s Hospital
Foundation and the Financial Markets Foundation for Children jointly
funded the study. The multi-disciplinary study was conducted by a
psycho-social researcher at the Central Queensland University (CQU) in
association with research clinicians from the Paediatric Haematology and
Oncology Unit of the Royal Children’s Hospital (RCH) and the Mater
Children’s Hospital (MCH), Brisbane, Australia. The study explo